Safety threshold of intravitreal activated protein-C

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 249, Issue 6, 2011, Pages 833-838

  Nishida, Kentaro ^a   Kamei, Motohiro ^a   Du, Zhao Jiang ^a   Xie, Ping ^a   Yamamoto, Takuhiro ^a   Suzuki, Mihoko ^a   Sakaguchi, Hirokazu ^a   Nishida, Kohji ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Activated protein C (APC); Intravitreal injection; Retina; Safety; Toxicity

Indexed keywords

ACTIVATED PROTEIN C; ANACT C; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHORIORETINA ATROPHY; CHORIORETINOPATHY; CONTROLLED STUDY; DOSE RESPONSE; DRUG SAFETY; ELECTRORETINOGRAM; EYE TOXICITY; HISTOPATHOLOGY; NONHUMAN; OPHTHALMOSCOPY; PRIORITY JOURNAL; RETINA; RETINA DEGENERATION; RETINA EDEMA; RETINA FLUORESCEIN ANGIOGRAPHY; SLIT LAMP; TOXICITY TESTING;

ANIMALS; ELECTRORETINOGRAPHY; FLUORESCEIN ANGIOGRAPHY; INTRAVITREAL INJECTIONS; OPHTHALMOSCOPY; PROTEIN C; RABBITS; RECOMBINANT PROTEINS; RETINA; VITREOUS BODY;

EID: 79959707183     PISSN: 0721832X     EISSN: 1435702X     Source Type: Journal    
DOI: 10.1007/s00417-010-1566-8     Document Type: Article

References (19)

1. Campochiaro PA (2000) Retinal and choroidal neovascularization. J Cell Physiol 184:301-310
2. Kaur C, Foulds WS, Ling EA (2008) Hypoxia-ischemia and retinal ganglion cell damage. Clin Ophthalmol 2:879-889
3. Fernández JA, Xu X, Liu D, Zlokovic BV, Griffin JH (2003) Recombinant murine-activated protein C is neuroprotective in a murine ischemic stroke model. Blood Cells Mol Dis 30:271-276 (Pubitemid 36539428)
4. Guo H, Liu D, Gelbard H, Cheng T, Insalaco R, Fernandez JA, Griffin JH, Zlokovic BV (2004) Activated protein C prevents neuronal apoptosis via protease activated receptors 1 and 3. Neuron 41:563-572 (Pubitemid 38253068)
5. Liu D, Cheng T, Guo H, Fernandez JA, Griffin JH, Song X, Zlokovic BV (2004) Tissue plasminogen activator neurovascular toxicity is controlled by activated protein C. Nat Med 10:1379-1383 (Pubitemid 40022721)
6. Zlokovic BV, Zhang C, Liu D, Fernandez JA, Griffin JH, Chopp M (2005) Functional recovery after embolic stroke in rodents by activated protein C. Ann Neurol 58:474-477 (Pubitemid 41266637)
7. Weiler H, Ruf W (2008) Activated protein C in sepsis: the promise of nonanticoagulant activated protein C. Curr Opin Hematol 15:487-493
8. Du Z, Yamamoto T, Ueda T, Suzuki M, Tano Y, Kamei M (2010) Activated protein C rescues the retina from ischemia-induced cell death. Invest Ophthalmol Vis Sci, doi:10.1167/iovs.10-5557
9. Morrison VL, Koh HJ, Cheng L, Bessho K, Davidson MC, Freeman WR (2006) Intravitreal toxicity of the kenalog vehicle (benzyl alcohol) in rabbits. Retina 26:339-344 (Pubitemid 44318189)
10. Domotor E, Benzakour O, Griffin JH, Yule D, Fukudome K, Zlokovic BV (2003) Activated protein C alters cytosolic calcium flux in human brain endotherium via binding to endotherial protein C receptor and activation of protease activated receptor-1. Blood 101:4797-4801 (Pubitemid 36857737)
11. Gorbacheva L, Pinelis V, Ishiwata S, Strukova S, Reiser G (2010) Activated protein C prevents glutamate-and thrombin-induced activation of nuclear factor-kappaB in cultured hippocamapal neurons. Neuroscience 165:1138-1146
12. Gupta A, Berg DT, Gerlitz B, Richardson MA, Galbreath E, Syed S, Sharma AC, Lowry SF, Grinnell BW (2007) Activated protein C suppresses adrenomedullin and ameliorate lipopolysaccharifde-induced hypotension. Shock 28:468-476 (Pubitemid 47415259)
13. Zachary IG, Forster RK (1976) Experimental intravitreal gentamicin. Am J Ophthalmol 82:604-611
14. McDonald HR, Schatz H, Allen AW, Chenoweth RG, Cohen HB, Crawford JB, Klein R, May DR, Snider JD 3rd (1986) Retinal toxicity secondary to intraocular gentamicin injection. Ophthalmology 93:871-877 (Pubitemid 16046094)
15. Rosenfeld PJ, Schwartz SD, Blumenkranz MS, Miller JW, Haller JA, Reimann JD, Greene WL, Shams N (2005) Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration. Ophthalmology 112:1048-1053 (Pubitemid 40797460)
16. Rosenfeld PJ, Fung AE, Puliafito CA (2005) Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion. Ophthalmic Surg Lasers Imaging 36:336-339 (Pubitemid 41073113)
17. Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ (2006) Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 113:363-372
18. Heier JS, Antoszyk AN, Pavan PR, Leff SR, Rosenfeld PJ, Ciulla TA, Dreyer RF, Gentile RC, Sy JP, Hantsbarqer G, Shams N (2006) Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multi-dose study. Ophthalmology 113:633
19. Jager RD, Aiello LP, Patel SC, Cunningham ET Jr (2004) Risks of intravitreous injection: a comprehensive review. Retina 24:676-698 (Pubitemid 39391758)